Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-23-000918
Filing Date
2023-09-13
Accepted
2023-09-13 19:32:17
Documents
1
Period of Report
2023-09-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 9209
  Complete submission text file 0000905148-23-000918.txt   10849
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES INC. 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Smith Brandon S. (Reporting) CIK: 0001805226 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35676 | Film No.: 231253784